AWS kicks in $20M to help combat COVID-19 with a new program

coronavirus
Amazon Web Service backs new diagnostic and research program to improve COVID-19 testing. (Pixabay)

Amazon Web Services (AWS) announced Friday that it's making an initial $20 million investment for a new diagnostic development program to fight COVID-19. With current testing results taking a day or more, AWS is putting its considerable resources behind finding and developing faster results.

The AWS Diagnostic Development Initiative is designed to "accelerate diagnostic research, innovation, and development to speed our collective understanding and detection of COVID-19."

"In our Amazon Web Services (AWS) business, one area where we have heard an urgent need is in the research and development of diagnostics, which consist of rapid, accurate detection and testing of COVID-19," said AWS's Teresa Carlson, in a blog. "Better diagnostics will help accelerate treatment and containment, and in time, shorten the course of this epidemic."

Sponsored by Anritsu Company

Free eBook: Efficient Testing Will Contribute to Long-Term Success in the 5G Marketplace

As companies worldwide race to launch 5G successfully and avoid post-deployment setbacks, we see a massive rise in the demand for 5G test and measurement equipment. We will discuss how efficient testing can contribute to long term success in 5G marketplace.

Carlson said the COVID-19 funding would be provided through a combination of AWS in-kind credits and technical support to assist its customers’ research teams while "harnessing the full potential of the cloud to tackle this challenge." The new program is launching with participation from 35 global research institutions, startups and businesses.

The program is open to accredited research institutions and private entities that are using AWS to support research-oriented workloads for the development of point-of-care diagnostics, which includes testing that can be done at home or at a clinic with same-day results. While the initial focus is on COVID-19, AWS will consider other disease-related diagnostic projects.

RELATED: Charter won’t let employees work from home during COVID-19

The program will also have the support of an outside technical advisory group that's made up of "leading scientists, global health policy experts, and thought leaders in the field of infectious disease diagnostics," the blog stated.

"We believe we can make a difference with the AWS Diagnostic Development Initiative program for several reasons," Carlson said. "First, accurate detection is the tip of the spear for any effective pandemic response strategy. Second, diagnostics research has historically been underfunded and largely deprioritized in favor of a focus on vaccines.

"Third, organizations working on diagnostics need reliable, scalable compute power, which we can deliver to them along with industry-leading services like analytics and machine learning, so they can process and analyze large data sets and iterate quickly."

AWS has set-up a webpage to provide more information on the program. As of this morning, there were 259,043 coronavirus cases worldwide and 10,545 deaths.

Suggested Articles

While some would argue that NFV doesn't deserve a third, fourth or fifth chance, MEF has thrown its support behind Lean NFV.

HPE has put the finishing touches on its $925 million deal to buy SD-WAN vendor Silver Peak, which narrows the gap on rivals such as Cisco and VMware.

AT&T and Akamai announced on Tuesday that they have extended their business partnership through 2023.